Related Experiment Videos
[Intrathecal morphine administration for oral and maxillofacial malignomas]
J Schramm1, J Neidhardt, W Spitzer
1Neurochirurgische Universitatsklinik, Bonn.
Abstract:
The intraventricular administration of morphine results in lesser systemic side effects, with an extremely satisfactorily pain relief going along with it (2, 5, 6). The subcutaneous pump which administers morphine intraventricularly is an interesting, non-destructive alternative of medium-term pain therapy for patients suffering from incurable pain caused by a malignant tumor in the oropharyngeal region. The morphine pump even makes it possible to go through terminal stages of the malignant disease well-relieved and in the familiar environment at home.
Insights
Intraventricular morphine administration via a subcutaneous pump offers effective pain relief with fewer systemic side effects. This method provides a non-destructive option for medium-term pain management in advanced cancer patients, enabling comfort at home.
Area of Science:
- Oncology
- Pain Management
- Pharmacology
Context:
- Malignant tumors in the oropharyngeal region often cause severe, incurable pain.
- Advanced cancer patients require effective pain management strategies for improved quality of life.
- Traditional pain management may lead to significant systemic side effects.
Purpose:
- To evaluate the efficacy and safety of intraventricular morphine administration for oropharyngeal cancer pain.
- To explore the use of a subcutaneous pump for medium-term pain therapy in palliative care.
- To assess the potential for improved patient comfort and home-based care during terminal stages.
Summary:
- Intraventricular morphine administration through a subcutaneous pump significantly reduces systemic side effects compared to other routes.
- This approach provides highly satisfactory pain relief for patients with incurable pain from oropharyngeal malignancies.
- The morphine pump facilitates a non-destructive, medium-term pain management solution, allowing patients to remain at home.
Impact:
- Offers a viable alternative for medium-term pain control in advanced cancer patients.
- Enhances patient comfort and quality of life, especially during terminal phases.
- Enables patients to spend their final stages of illness at home in a familiar environment, well-relieved from pain.